| Literature DB >> 30587973 |
Ruolan Wang1, Bin Song2, Junrong Wu1, Yanli Zhang1, Aijie Chen1, Longquan Shao1,3.
Abstract
With the vigorous development of nanometer-sized materials, nanoproducts are becoming widely used in all aspects of life. In medicine, nanoparticles (NPs) can be used as nanoscopic drug carriers and for nanoimaging technologies. Thus, substantial attention has been paid to the potential risks of NPs. Previous studies have shown that numerous types of NPs are able to pass certain biological barriers and exert toxic effects on crucial organs, such as the brain, liver, and kidney. Only recently, attention has been directed toward the reproductive toxicity of nanomaterials. NPs can pass through the blood-testis barrier, placental barrier, and epithelial barrier, which protect reproductive tissues, and then accumulate in reproductive organs. NP accumulation damages organs (testis, epididymis, ovary, and uterus) by destroying Sertoli cells, Leydig cells, and germ cells, causing reproductive organ dysfunction that adversely affects sperm quality, quantity, morphology, and motility or reduces the number of mature oocytes and disrupts primary and secondary follicular development. In addition, NPs can disrupt the levels of secreted hormones, causing changes in sexual behavior. However, the current review primarily examines toxicological phenomena. The molecular mechanisms involved in NP toxicity to the reproductive system are not fully understood, but possible mechanisms include oxidative stress, apoptosis, inflammation, and genotoxicity. Previous studies have shown that NPs can increase inflammation, oxidative stress, and apoptosis and induce ROS, causing damage at the molecular and genetic levels which results in cytotoxicity. This review provides an understanding of the applications and toxicological effects of NPs on the reproductive system.Entities:
Keywords: ROS; nanoparticles; ovary; reproductive; sperm; toxic
Mesh:
Year: 2018 PMID: 30587973 PMCID: PMC6294055 DOI: 10.2147/IJN.S170723
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Adverse effect of NPs in the reproductive cell organs and molecules.
Abbreviations: E2, estradiol; FSH, follicle-stimulating hormone; LH, luteinizing hormone; NPs, nanoparticles; PRL, prolactin; T, testosterone.
Adverse effect of NPs on the reproductive system
| Drug | Model | Exposure time | Dose | Index | Result | References |
|---|---|---|---|---|---|---|
| Single-walled carbon nanotubes | Human sperm | 0.5–3 hours (0 minute, 30 minutes, 3 hours) | 1–25 µg/mL (1, 5, 25 µg/mL) | Viability, VCL, VSL, ROS, and NOS levels of sperm | 1. Not affect sperm viability | Asghar et al |
| Reduced GO | Human sperm | 0.5–3 hours (0 minute, 30 minutes, 3 hours) | 1–25 µg/mL (1, 5, 25 µg/mL) | Viability, VCL, VSL, ROS, and NOS levels of sperm | 1. Not affect sperm viability | Asghar et al |
| GO (2.496 nm) | SSCs | 24 hours | 0, 1, 10, 100, and 400 g/mL | MTT, ROS, comet assay, acridine orange staining | 1. Spermatogonial colonies, viable cells ↓ | Hashemi et al |
| Reduced GO | SSCs | 24 hours | 0, 1, 10, 100, and 400 g/mL | MTT, ROS, comet assay, acridine orange staining | 1. Negative impact on cell morphology | Hashemi et al |
| Zinc oxide (50 nm) | Mouse Sertoli cell line (TM-4) and spermatocyte cell line (GC2-spd) | 24 hours | 0, 0.04, 0.08, 0.4, 0.8, 4, 8, and 16 µg/mL | Viability assay, ROS, high-content screening assay, protein preparation and Western blot assay, immunofluorescence assay, TNF-α level, cell-cycle analysis | 1. ROS ↑ | Liu et al |
| AgNPs (412 nm) | TM-3, TM-4, mice (male) | Abdominal subcutaneous injection five times ([PND] 8–21) | 0, 1, and 5 mg/kg | MTT, LDH leakage assay, histological examination, RT-PCRs, analyses of Mlh1 signals, sperm analysis | 1. Sperm abnormalities ↑ | Zhang et al |
| AgNPs (60 nm) | Prepubertal male Wistar rats | Orally treated (PND23 to PND58) sacrificed at PND102 | 15 or 30 mg/kg/day | Acrosome integrity, plasma membrane integrity, mitochondrial activity, morphological alterations of the sperm, sexual partner preference, sexual behavior, and the serum concentrations of FSH, LH, T, and E2 | 1. Acrosome and plasma membrane integrities ↓ | Mathias et al |
| 14 nm carbon NPs | Forty pregnant ICR mice and 120 male offspring | Intratracheally on days 7 and 14 of gestation | 200 mg | Maternal and fetal growth, histological changes in the testes, and DSP | 1. Partial vacuolation of seminiferous tubules | Yoshida et al |
| Iron oxide NPs (positively charged polyethyleneimine-Fe2O3-NPs (PEI-NPs), 28 nm, or negatively charged poly(acrylic acid)-Fe2O3-NPs (PAA-NPs)), 30 nm | CD1 (ICR; CD-1) mice | GD: 8, 9, or 10 | 10 and 100 mg/kg | Morbidity, mortality, behavioral changes, and alterations in general appearance, fetuses were weight, externally examined, reproductive organs, histological, mating, second-generation ability to become pregnant and produce viable offspring | 1. A low dose of NPs, regardless of charge, did not induce toxicity. However, a high exposure led to charge-dependent fetal loss as well as morphological alterations of the uteri (both charges) and testes (positive only) of surviving offspring | Di Bona et al |
| CdTe QDs (2.0 nm) | Male BALB/c mice (18e22 g) | Intravenously (animals were sacrificed at 3 hours and 1, 3, 7, 15, 30, 60, and 90 days after the injection) | 2.0 nmol per mouse and a low dose of 0.2 nmol per mouse | ICP-MS, histology, T, LH, FSH (RIA), sperm morphology, sperm nuclear DNA integrity, fertility | 1. High dose of CdTe affected body weight up to 15 days after exposure | Li et al |
| AgNPs | Prepubertal male Wistar rats | Orally by gavage (from PND23 until PND53) | 0, 15, or 50 µg/kg | Daily weight, sperm count in testes and epididymis, morphology and morphometry of seminiferous epithelium, T and E2 levels | 1. The weight did not change markedly, but growth was less | Sleiman et al |
| ZnO NPs (30–70 nm) | Human semen samples | 180 minutes | 10, 100, 500, and 1,000 µg/mL | MTT | 1. Cell death percentage ↑ | Barkhordari et al |
| NiNPs (90 nm) | SD rats | Gavage: 10 weeks | 0, 5, 15, 45 mg/kg | Body weight, organ weight, sex hormone levels, sperm motility, histopathology, and reproductive outcome | 1. FSH, LH ↑, E2 serum levels ↓ | Kong et al |
| SiNPs (57.66 nm) | C57 male mice | Tracheal perfusion every 3 days for 45 days (in total 15 times) | 2 mg/kg | Sperm motility, histological structure and ultrastructure of testes, apoptosis of spermatogenic cells (TUNEL), oxidative stress indices in the testes (SOD, MDA, 3-NT), protein expression in rIPK1 signal pathway (Western blots) | 1. Malformation of sperm ↑, motility and concentration of sperm ↓ in epididymis | Ren et al |
| Amorphous nSPs (300 nm) | BALB/c mice (male, 9 weeks old) | Tail vein injected intravenously at 2 days/4 days | 0.4 and 0.8 mg | Histology, ALT, AST, BUN, TEM | 1. nSP70 were detected within Sertoli cells and spermatocytes, including in the nuclei of spermatocytes | Morishita et al |
| PbS NPs (30 nm) | SD rats (180–240 g body weight 12–14 weeks) | Gavage once a day, 5 days a week, continued exposure for 6 weeks | 0, 25, 50, 100 mg/kg | Body weight, testicular coefficient, serum T levels, sperm survival rate, sperm abnormality rate, lead content measurements in the testis, pathology | 1. Autonomic activities ↓, marked listlessness, coarse surface skin or depilation, food consumption, water drinking ↓, fur luster ↓, slowed response | Cao et al |
| Titanium dioxide NPs | albino rats (180–200 g) | Orally for 8 weeks | 100 mg/kg/day | Serum T level, organ weights, histopathological, body weight, sperm motility, morphology, and concentration | 1. Body weight and testis, epididymis, seminal vesicle, and prostate gland weights ↓ | Morgan et al |
| Graphene NMs (GNPs–pristine, COOH and NH2) and GOs (SLGO and FLGO) 450 nm | Human bronchial epithelial cells; nematode | 1.24 hours, 2.4–72 hours, 3.10 days in vivo, 4.72 hours | 1.5–150 mg/L of five different GFNs 2.20 mg/L and GOs 50, 3.10, and 50 mg/L in vivo 4.5–50 mg/L mixed in K-media | Colony formation assays, cell viability and cytotoxicity, morphology | 1. GNPs exhibited higher toxicity than GOs in Beas2B cells | Chatterjee et al |
| AgNPs (20 and 200 nm) | 14-week-old male Wistar rats | I.v. single dose (tail vein) | 5 and 10 mg/kg body mass | Epididymal sperm count and sperm morphology, Sperm cell DNA damage (alkaline comet assay), histological | 1. Epididymal sperm count ↓ | Gromadzka-Ostrowska et al |
| AgNPs (10 nm) | CD1 | Intravenously injected | 1 mg/kg/dose 12 days | ICP-MS, testis stereology, Leydig cell counts and numbers, computer-assisted sperm analysis, mating assay, endocrinology (LH, FSH, T, IGF1), steroidogenic mRNA in the testis | 1. No changes in body and testis weights | Garcia et al |
| GNRs (9–11 × 34–42 nm) | TM-4, GC2 | 24 hours | 0.1, 1, and 10 nM | TEM, MTT, flow cytometric analysis, metabolomic analysis, RNA isolation and quantitative RT-PCR assay, mRNA levels of glycine synthesizing enzyme genes (SHMT2, MTHFD1L, SHMT1, and MTHFD1), expression levels of junction factors (claudin-5, occludin, ZO-1, connexin-43, and GAPDH), content screening assay, ROS content, cellular ATP levels, mitochondrial membrane potential assay by JC-1 | 1. Glycine ↓ | Xu et al |
| AgNPs (20 and 200 nm) | Ntera2, primary testicular cells from C57BL6 mice of wild type, 8-oxoguanine DNA glycosylase knockout, 8–12-week-old male 8-oxoguanine DNA glycosylase knockout mice | 24/48/72 hours | 10/50/100 g mL−1 | MTT, PI/Hoechst staining (cell death), membrane integrity, nuclear morphology, single-cell gel electrophoresis, comet assay, cytokine assay | 1. Cell number ↓ | Asare et al |
| Water-soluble MWCNTs | Male BALB/c mice (20–25 g) | Repeated i.v. injections | 15 days single dose, 15 days multi-dose, 60 days multi-dose, and 90 days multi-dose groups for controls, COOH nanotubes, and amine nanotubes of 1.0 mg/mL | Sperm concentration, sperm movement, sperm morphological abnormalities, histological, oxidative stress, hormone measurements, fertility evaluations, TUNEL assay | 1. Cause reversible testis damage without affecting fertility | Bai et al |
| Mesoporous silica NPs | Boar sperm | 2, 3, and 4 hours | 10, 15, and 30 µg of particles per 107 sperm | TEM and SEM, sperm motility, viability, and association rates with MSNPs, acrosome morphology, sperm DNA fragmentation index | 1. Did not significantly detriment mean proportions of sperm motile | Barkalina et al |
| AgNPs | SSCs | 1. Decline in SSC proliferation | ||||
| Nano-TiO2 (5–6 nm) | CD-1 (ICR) female mice | 90 consecutive days (intragastric administration) | 2.5, 5, and 10 mg/kg | Weight, ICP-MS, hematological, Cell-DYN 3700, sex hormone assays, histopathological, confocal Raman microscopy, RT-PCR, ELISA | 1. Body weight, ovary weight ↓ decreased | Zhao et al |
| FeNPs | ICR mice | 14 days | 1, 2, and 4 mg/kg | Blood analysis, histopathological, microarray, and ingenuity pathway analysis, immunohistochemistry, cell counts, cell-cycle analysis, cytokine assays, immunophenotypic analysis | 1. Body weight gain ↓ | Park et al |
| 1. NPs disturb the developing oocytes by invading the protective barrier of theca cells, granulosa cell layers, and zona pellucida | Hou and Zhu | |||||
| Polymeric NP poly(ethylene glycol)-block-polylactide methyl ether (PeG-bPLA) (50 nm) | Wistar rats | Single dose (single i.v. injection) | 20 or 40 mg/kg | Histopathological, body, and organ weights, vaginal opening, estrous cyclicity, hormone measurements | 1. Regular estrous cycles ↓ | Rollerova et al |
Note: ↑= increased; ↓=decreased.
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; AgNPs, silver nanoparticles; Amh, adrenal medullary hormone; APEI apurinic/apyrimidinic ndonuclease 1; BTB, blood–testis barrier; BUN, blood urea nitrogen; Cx43, connexin43; CYP, cyclophilin periplasmic; CdTe, cadmium telluride; COOH, carboxylate; DSP, daily sperm production; E2, estradiol; FLGO, few-layer graphene oxide; FADD, Fas-associating protein with a novel death domain; FSH, follicle-stimulating hormone; GFNs, graphene NMs; GD, gestation day; GNPs, graphene nanoplatelets; GNRs, gold nanorods; GO, graphene oxide; HGB, hemoglobin; ICR, Institute of Cancer Research; IGFBP, insulin like growth factor binding protein; ICP-MS, inductively coupled plasma mass spectrometry; i.v., intravenous; LDH, lactate dehydrogenase; LH, luteinizing hormone; LHR, luteinizing hormone receptor; LYMPH , lymphocyte; MSNPs, mesoporous silica NPs; MDA, malondialdehyde; MHC, major histocompatibility complex; MLKL, mixed lineage kinase domain like pseudokinase; MWCNTs, multiwalled carbon nanotubes; NH2, amide; NM, nanomaterial; NOS, nitric oxide synthase; NEUT, neutrophilic granulocyte count; NP, nanoparticle; nSPs, nanosilica particles; PbS, lead sulfide; PEG-b-PLA, poly(ethylene glycol)-block-poly(d,l-lactic acid); PI, propidium iodide; P4, progesterone; PND, postnatal day; QD, quantum dot; RBC, red blood cell; RIA, radioimmunoassay; RT-PCR, real-time PCR; SD, Sprague Dawley; SOD, superoxide dismutase; SEM, scanning electron microscope; SLGO, single-layer graphene oxide; SSCs, spermatogonial stem cells; tPA, tissue plasminogen activator; T, testosterone; TEM, transmission electron microscopy; WBC, white blood cells; VCL, curvilinear velocity; VSL, straight line velocity.